# üó∫Ô∏è Roadmap - Agente Daktus QA

**Last Updated**: 2025-11-29  
**Status**: ‚úÖ Agent V2 Complete - All Phases Implemented (Production Ready)

---

## üéØ Product Vision

**Mission**: Provide automated, AI-powered validation of clinical protocols against evidence-based medical playbooks, ensuring clinical safety, completeness, and adherence to best practices.

**Core Principles**:
- **Zero clinical logic in code** - all clinical intelligence from LLM
- **Specialty-agnostic** - same system for all medical specialties
- **Evidence-based** - validation against authoritative playbooks
- **Actionable insights** - specific, implementable improvement suggestions

**Non-Goals**:
- ‚ùå Not a protocol editor (read-only validation)
- ‚ùå Not a clinical decision support system (validation only)
- ‚ùå Not specialty-specific (agnostic design)

---

## ‚úÖ Current Status (v2.2)

### Implemented Features

#### Core Functionality
- ‚úÖ Protocol JSON parsing and structural validation
- ‚úÖ Playbook extraction (Markdown/PDF) via LLM
- ‚úÖ Clinical gap analysis (protocol vs playbook)
- ‚úÖ Efficiency analysis (variable impact assessment)
- ‚úÖ Improvement suggestions (via LLM)
- ‚úÖ Report generation (text + JSON)

#### Agent V2 (Simplified Architecture) - Phase 1 ‚úÖ
- ‚úÖ ContentLoader - raw file loading (no interpretation)
- ‚úÖ PromptBuilder - super prompt assembly
- ‚úÖ LLMClient - OpenRouter integration
- ‚úÖ SimplifiedQARunner - orchestration (zero clinical logic)
- ‚úÖ ResponseValidator - schema validation
- ‚úÖ LegacyAdapter - format conversion for compatibility
- ‚úÖ Feature flag system (`USE_SIMPLIFIED_AGENT`)
- ‚úÖ Shared logging infrastructure
- ‚úÖ Single LLM call for all analysis (including semantic)

#### Infrastructure
- ‚úÖ CLI interface (`run_qa_cli.py`)
- ‚úÖ Structured logging (`logs/qa_analysis_*.log`)
- ‚úÖ Error handling and fail-fast logic
- ‚úÖ Model catalog (5 supported models)
- ‚úÖ OpenRouter API integration

#### Testing
- ‚úÖ Unit tests (structure validation)
- ‚úÖ Integration tests (Agent V2 compatibility)
- ‚úÖ Compliance tests (12/12 criteria met)
- ‚úÖ Real protocol testing (ORL, AVC, Reumatologia)

---

## ‚úÖ Phase 2: Integration and Schema Compatibility (‚úÖ Complete)

**Status Update (2025-11-29)**: ‚úÖ Pipeline √∫nico funcionando, sistema limpo e consolidado. Phase 3 completada.

### Goals
- Make Agent V2 the default execution path
- Ensure full compatibility with downstream components
- Monitor production usage
- Validate quality metrics

### Tasks

#### 2.1 Agent V2 as Default ‚úÖ (Partially Complete)
- ‚úÖ Feature flag system implemented
- ‚úÖ Legacy fallback on Agent V2 failure
- ‚è≥ **TODO**: Set `USE_SIMPLIFIED_AGENT=true` by default
- ‚è≥ **TODO**: Monitor production metrics (success rate, latency, quality)

#### 2.2 Schema Compatibility
- ‚úÖ LegacyAdapter converts Agent V2 output to legacy format
- ‚úÖ Compatible with `semantic_analyzer.py` (via adapter)
- ‚úÖ Compatible with `report_generator.py` (via adapter)
- ‚è≥ **TODO**: Validate all edge cases
- ‚è≥ **TODO**: Performance testing with large playbooks

#### 2.3 Fallback Elimination
- ‚úÖ Fallbacks disabled when Agent V2 active
- ‚úÖ Structured errors instead of hardcoded clinical logic
- ‚è≥ **TODO**: Remove hardcoded fallbacks from codebase (Phase 3)
- ‚è≥ **TODO**: Document fallback behavior clearly

#### 2.4 Observability
- ‚úÖ Structured logging implemented
- ‚úÖ Performance metrics (latency, tokens, costs)
- ‚è≥ **TODO**: Dashboard for metrics visualization
- ‚è≥ **TODO**: Alerting for failures

**Target Completion**: 2025-11-29 ‚úÖ **COMPLETED**

---

## ‚úÖ Phase 3: Complete Migration and Legacy Removal (‚úÖ Complete)

### Goals
- Remove all legacy code
- Agent V2 as only architecture
- Clean codebase (remove hardcoded clinical logic)
- Update downstream components to use new schema natively

### Tasks

#### 3.1 Legacy Code Removal (‚úÖ Complete)
- ‚úÖ Remove `semantic_protocol_analyzer.py` (hardcoded fallbacks) - **COMPLETO**
- ‚úÖ Remove `protocol_improvement_analyzer.py` - **COMPLETO**
- ‚úÖ Remove `LegacyAdapter` (no longer needed) - **COMPLETO**
- ‚úÖ Remove `SchemaAdapter` (no longer needed) - **COMPLETO**
- ‚úÖ Remove duplicate loaders (`loader.py` duplicado) - **COMPLETO**
- ‚úÖ Remove obsolete CLIs (`cli_interface.py`, `cli_interface_refactored.py`) - **COMPLETO**
- ‚úÖ Remove empty DDD folders (`presentation/`, `domain/`, `infrastructure/`, `use_cases/`, `analysis/`) - **COMPLETO**
- ‚úÖ Remove `qa_agent.py` legacy agent - **COMPLETO**
- ‚úÖ Remove semantic coverage feature (legacy) - **COMPLETO**
- ‚úÖ Clean up unused imports and dependencies - **COMPLETO**
- ‚úÖ Pipeline √∫nico funcionando: `agent_v2.pipeline.analyze()` - **COMPLETO**
- ‚úÖ Sistema 100% Agent V2, zero legacy - **COMPLETO**

#### 3.2 Schema Migration (‚úÖ Complete)
- ‚úÖ Pipeline √∫nico com output simplificado (sem semantic_coverage)
- ‚úÖ Foco exclusivo em `improvement_suggestions` como core feature
- ‚úÖ Output format: `protocol_analysis`, `improvement_suggestions`, `metadata`

#### 3.3 Documentation Cleanup (‚úÖ Complete)
- ‚úÖ Obsolete documentation files removed
- ‚úÖ All references updated to new architecture
- ‚úÖ Documentation consolidated in master files (README, roadmap, dev_history)

**Target Completion**: 2025-11-29 ‚úÖ **COMPLETED**

---

## üéØ Future Features (Backlog)

### High Priority

#### Chunking Strategy for Large Playbooks
**Problem**: Playbooks >50 pages may exceed LLM context window  
**Solution**: Implement chunking with synthesis step
- Split playbook into chunks
- Analyze each chunk separately
- Synthesize results in final step
**Status**: ‚è≥ Planned for Phase 2

#### Prompt Optimization
**Goal**: Improve LLM output quality and consistency
- A/B testing different prompt templates
- Specialty-specific prompt sections (configurable, not hardcoded)
- Few-shot examples for better extraction
**Status**: ‚è≥ Ongoing improvement

#### Cost Tracking
**Goal**: Track and optimize LLM costs
- Per-analysis cost logging
- Budget alerts
- Cost optimization recommendations
**Status**: ‚è≥ Planned

### Medium Priority

#### Web Interface
**Goal**: User-friendly web UI for non-technical users
- Streamlit dashboard
- Drag-and-drop file upload
- Interactive visualization of results
- Export functionality
**Status**: ‚è≥ Planned for Q1 2026

#### Batch Processing
**Goal**: Analyze multiple protocols at once
- Directory scanning
- Parallel processing
- Summary reports
**Status**: ‚è≥ Planned

#### Version Comparison
**Goal**: Compare protocol versions over time
- Track changes between versions
- Highlight improvements
- Regression detection
**Status**: ‚è≥ Planned

### Low Priority

#### API Server
**Goal**: REST API for integration with other systems
- FastAPI server
- Authentication
- Rate limiting
**Status**: ‚è≥ Future consideration

#### Automated Protocol Improvement
**Goal**: Automatically apply simple improvements
- Preview before applying
- Rollback capability
- Human approval workflow
**Status**: ‚è≥ Future consideration (v3.0)

---

## üîÑ Specialty-Agnostic Design

### Current Approach

**Agent V2** is fully specialty-agnostic:
- Same code path for all specialties
- No `if specialty == "ORL"` logic
- Specialty knowledge comes from playbooks, not code

### Configurable Prompts (Future)

While code remains agnostic, prompts can be optimized per specialty:

```yaml
# config/prompts.yaml (future)
base_qa_analysis:
  clinical_extraction: "Extract all clinical elements..."
  structural_analysis: "Analyze JSON structure..."

specialty_overrides:
  orl:
    additional_focus: "Pay special attention to audiology patterns..."
  avc:
    additional_focus: "Emphasize timing of interventions..."
```

**Note**: This is prompt configuration, not code logic. Code remains identical.

---

## üìä Success Metrics

### Quality Metrics
- **Coverage accuracy**: ‚â• 90% (vs manual validation)
- **False positive rate**: ‚â§ 5%
- **Suggestion relevance**: ‚â• 80% implementable

### Performance Metrics
- **Latency p95**: ‚â§ 60 seconds (Agent V2)
- **Success rate**: ‚â• 95%
- **Cost per analysis**: ‚â§ $0.10 (with recommended model)

### Adoption Metrics
- **Active users**: [Track when available]
- **Protocols analyzed**: [Track when available]
- **Improvements implemented**: [Track when available]

---

## üö® Known Limitations

### Current Limitations

1. **Large Playbooks**
   - Playbooks >50 pages may exceed context window
   - **Mitigation**: Chunking strategy (planned for Phase 2)

2. **LLM Dependency**
   - System requires LLM API access
   - **Mitigation**: Structured error responses when LLM unavailable

3. **Cost**
   - Each analysis costs ~$0.05-0.10
   - **Mitigation**: Free tier models available (`grok-4.1-fast:free`)

4. **Language**
   - Currently optimized for Portuguese (Brazilian)
   - **Mitigation**: Prompts can be adapted for other languages

---

## üìÖ Timeline Summary

| Phase | Status | Target | Key Deliverables |
|-------|--------|--------|------------------|
| **Phase 1** | ‚úÖ Complete | 2025-11-29 | Agent V2 foundation, modules created, system functional |
| **Phase 2** | ‚úÖ Complete | 2025-11-29 | Agent V2 √∫nico pipeline, unified system, imports fixed |
| **Phase 3** | ‚úÖ Complete | 2025-11-29 | Legacy removal complete, semantic coverage removed, production ready |

**Conforme REVIEW_CLAUDE.txt:**
- ‚úÖ **Phase 1 (Foundation)**: COMPLETA - Agent V2 implementado e funcional
- ‚úÖ **Phase 2 (Integration)**: COMPLETA - Pipeline √∫nico, sistema unificado, 100% Agent V2
- ‚úÖ **Phase 3 (Legacy Removal)**: COMPLETA - Legacy removido, semantic coverage removido, sistema limpo e funcional

| **Future** | ‚è≥ Backlog | TBD | Web UI, batch processing, API server |

---

## ü§ù Contributing to Roadmap

**Process**:
1. Discuss feature requests in issues
2. Update this roadmap with approved features
3. Add to appropriate phase/priority
4. Update `dev_history.md` when implementing

**Principles**:
- Maintain specialty-agnostic design
- No hardcoded clinical logic
- All changes must align with Agent V2 architecture

---

**For development history, see [`dev_history.md`](dev_history.md)**  
**For usage instructions, see [`readme.md`](readme.md)**

